Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) Refractory status epilepticus in genetic Creutzfeldt-Jakob disease with E200K mu...
Journal Information
Vol. 35. Issue 9.
Pages 712-714 (November - December 2020)
Vol. 35. Issue 9.
Pages 712-714 (November - December 2020)
Letter to the Editor
Open Access
Refractory status epilepticus in genetic Creutzfeldt-Jakob disease with E200K mutation
Status epiléptico refractario en enfermedad de Creutzfeldt-Jakob genética por mutación E200K
A. Gómez Roldósa, E. Esteban de Antonioa, M. Pérez-Chirinos Rodríguezb, J.R. Pérez Sáncheza,
Corresponding author

Corresponding author.
a Servicio de Neurología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
b Servicio de Neurofisiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
Article information
Full Text
Download PDF
Figures (2)
Full Text
Dear Editor:

Creutzfeldt-Jakob disease (CJD) is the most common prion disease in humans. It is caused by accumulation of abnormally folded prion proteins in the central nervous system. By aetiology, it is classified as sporadic, acquired, or genetic.1 Between 10% and 15% of cases are caused by mutations in the prion protein gene (PRNP), with E200K being the most common mutation. The disease manifests with rapidly progressive cognitive impairment, cerebellar signs, and myoclonus, and presents a progressive fatal course. Seizures are reported in less than 15% of sporadic cases of CJD.2,3

We present the case of a 48-year-old white man with personal history of arterial hypertension, dyslipidaemia, and chronic tobacco and cannabis use. He had no relevant family history or prior treatments. The patient was admitted due to speech and gait alterations of 2 months’ progression. At admission, he presented predominantly motor aphasia and gait ataxia. Physical examination identified dysphasia, disinhibited behaviour with psychomotor agitation and unprovoked laughter, bilateral grasping reflex, dystonia in the left hand, dysmetria in the upper limbs, stimulus-induced multifocal myoclonus, and cerebellar ataxia. A complete blood analysis including serology and autoimmunity studies revealed no pathological findings. The cerebrospinal fluid (CSF) was acellular with slightly elevated protein levels; microbiological findings were negative and a 14-3-3 assay was positive. Brain magnetic resonance imaging (MRI) showed FLAIR hyperintensity in both caudate nuclei and diffusion restriction in the putamina, both caudate nuclei, frontal and temporal parasagittal areas, and both cingulate gyri, with left predominance (Fig. 1). On the third day after admission the patient presented an episode of tonic ocular deviation to the right and altered level of consciousness, of 2-3 minutes’ duration, which suggested a secondarily generalised focal seizure. During the first 2 weeks after admission, 6 electroencephalography (EEG) studies were performed, revealing pseudoperiodic discharges of generalised, predominantly left biphasic and triphasic sharp waves with spikes/polyspikes (Fig. 2). Despite antiepileptic treatment with levetiracetam at 2000 mg/24 hours, on day 11 he presented secondarily generalised status epilepticus with EEG correlate, which was responsive to clonazepam. The patient was transferred to the intensive care unit, and progressed poorly despite treatment with multiple antiepileptics (levetiracetam, lacosamide, phenytoin, clonazepam, midazolam, and propofol) and immunomodulation with corticosteroids and immunoglobulins. Genetic testing for CJD confirmed homozygous presence of the E200K mutation of the PRNP gene, with methionine at codon 129 (MM genotype). The patient died 3 weeks after admission. The neuropathological examination showed widespread vacuolisation and transcortical astrocytosis, which were particularly intense in limbic regions and the temporal neocortex; these findings are compatible with diagnosis of CJD.

Figure 1.

Brain MRI. (A) FLAIR sequence showing hyperintensity in both caudate nuclei. (B) DWI sequence showing diffusion restriction in the putamina and caudate nuclei, frontal and temporal parasagittal areas, and both cingulate gyri, with left predominance.

Figure 2.

EEG studies performed on the third (left) and fifth (right) days after admission, showing generalised biphasic and triphasic sharp-wave complexes, repeated with variable periodicity.


The clinical presentation, with rapidly progressive cognitive impairment and ataxia, multifocal myoclonus, and focal dystonia, led us to suspect a prion encephalopathy as the most likely diagnosis. Differential diagnosis included autoimmune encephalitis, infectious encephalitis, toxic/deficiency and metabolic encephalopathies, vasculitis, and leptomeningeal carcinomatosis. Due to the episode of status epilepticus, we considered the possibility of autoimmune encephalitis, after ruling out herpes simplex encephalitis, and started empirical treatment with corticosteroids and immunoglobulins. In addition to the characteristic clinical presentation and rapid progression, one of the key clinical findings prompting suspicion of CJD was the presence of myoclonus.

CJD is a rare neurodegenerative disease; diagnosis of probable CJD is based on clinical, EEG, neuroimaging, and laboratory findings. The genetic form follows an autosomal dominant inheritance pattern. However, as in our patient’s case, more than 60% of patients with genetic CJD do not have family history of the condition.4,5 For this reason, diagnosis of genetic CJD can be challenging.

In early stages of the disease, EEG findings may be normal or pathological, with non-specific diffuse theta or delta rhythm, frontal intermittent rhythmic delta activity (FIRDA), or periodic lateralised epileptiform discharges (PLED). The characteristic periodic sharp-wave complexes (PSWC) appear in 66% of patients with sporadic CJD and in 10% of patients with genetic CJD, usually in advanced stages.6 PSWCs correlate with cortical involvement observed in MRI studies, which is more common in sporadic forms.7 Status epilepticus has been reported in few cases of sporadic CJD8 and in only 2 cases of familial CJD.9,10

Our patient had genetic CJD in the absence of family history, and presented an episode of status epilepticus, which is unusual in sporadic CJD, and even rarer in the genetic form. Although the typical PSWCs did not appear on the EEG, the performance of multiple EEGs enabled us to identify pseudoperiodic biphasic and triphasic sharp-wave complexes, which are highly suggestive of CJD, despite not being considered a diagnostic criterion. The significant temporal cortex involvement observed in the MRI study and confirmed in the neuropathological examination may explain the seizures and therefore the rapid progression.

In conclusion, this case demonstrates the phenotypic variability of CJD: it is one of the few reported cases of refractory focal status epilepticus in a patient with genetic CJD. Finally, we should stress the importance of performing serial EEG and genetic studies when a prion disease is suspected.

Presentations at congresses

This study was presented at the 71st Annual Meeting of the Spanish Society of Neurology.


This study has received no public or private funding.

Conflicts of interest

The authors have no conflicts of interest to declare.

B.L. Tee, E.M. Longoria Ibarrola, M.D. Geschwind.
Prion diseases.
Neurol Clin, 36 (2018), pp. 865-897
S. Appel, J. Chapman, O.S. Cohen, H. Rosenmann, Z. Nitsan, I. Blatt.
Seizures in E200K familial and sporadic Creutzfeldt-Jakob disease.
Acta Neurol Scand, 131 (2015), pp. 152-157
P.S. Espinosa, M.K. Bensalem-Owen, D.B. Fee.
Sporadic Creutzfeldt-Jakob disease presenting as nonconvulsive status epilepticus case report and review of the literature.
Clin Neurol Neurosurg, 112 (2010), pp. 537-540
G.G. Kovacs, M. Puopolo, A. Ladogana, M. Pocchiari, H. Budka, C. van Duijn, et al.
Genetic prion disease: the EUROCJD experience.
Hum Genet, 118 (2005), pp. 166-174
J.S. Goldman, B.L. Miller, J. Safar, S. de Tourreil, J.L. Martindale, S.B. Prusiner, et al.
When sporadic disease is not sporadic: the potential for genetic etiology.
Arch Neurol, 61 (2004), pp. 213-216
H.G. Wieser, K. Schindler, D. Zumsteg.
EEG in Creutzfeldt–Jakob disease.
Clin Neurophysiol, 117 (2006), pp. 935-995
S.A. Appel, J. Chapman, I. Prohovnik, C. Hoffman, O.S. Cohen, I. Blatt.
The EEG in E200K familial CJD: relation to MRI patterns.
J Neurol, 259 (2012), pp. 491-496
I. Zerr, S. Poser.
Clinical diagnosis and differential diagnosis of CJD and vCJD.
M.R. Lowden, K. Scott, M.J. Kothari.
Familial Creutzfeldt-Jakob disease presenting as epilepsia partialis continua.
Epileptic Disord, 10 (2008), pp. 271-275
M.Y. Neufeld, A. Talianski-Aronov, D. Soffer, A.D. Korczyn.
Generalized convulsive status epilepticus in Creutzfeldt-Jakob disease.

Please cite this article as: Gómez Roldós A, Esteban de Antonio E, Pérez-Chirinos Rodríguez M, Pérez Sánchez JR. Status epiléptico refractario en enfermedad de Creutzfeldt-Jakob genética por mutación E200K. Neurología. 2020;35:712–714.

Copyright © 2020. Sociedad Española de Neurología
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos